Source: Health Policy Institute of Ohio
A study released by the Ohio Department of Health and The Ohio State University found that, as of July, the prevalence of COVID-19 antibodies in Ohio was relatively low (Source: “Coronavirus: Antibody Study Shows Prevalence Low in Ohio Adults, Many Still Susceptible,” Dayton Daily News, October 2, 2020).
The results of the antibody study, which included 720 randomly selected volunteers, found that 0.9% had active COVID-19 and 1.5% had evidence of antibodies when tested over 20 days in July. Blood samples and nasal swabs were collected to test for the presence of antibodies and active COVID-19. Given Ohio’s population size, those percentages would equal about 101,700 active COVID-19 cases and 169,500 Ohioans with antibodies, which means more than 11.1 million out of 11.3 million Ohioans would still be susceptible to getting the virus.